Page 3 - Supercritical Fluids News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ceapro Inc Reports Record 2022 Second Quarter and

– Company boasts highest second quarter sales to date; Q2 2022 sales of $5,500,000 vs $4,409,000 in Q2 2021, a 25% increase – YTD Sales increased 28% vs.

Gilles gagnonBernhard seifriedGenevieve fosterBeta glucanMontreal heart instituteUniversity of albertaMcmaster universityCompany board of directorsPipeline developmentCorealis incCeapro incManufacturing servicesHealth canadaInternational symposium on supercritical fluidsProcessed alginatesInternational symposium

Ceapro Inc Announces Publication of Positive Results for

– PGX Technology continues to demonstrate the ability to generate superior novel bioactive delivery systems – Findings from the collaborative project with.

Bernhard seifriedGilles gagnonPaul moquinZixiang liuRicardo coutoXpanded liquid technologyUniversity of albertaDepartment of agriculturalEngineering researchCeapro incFeral temelli at university of albertaSupercritical fluidsFeral temelliSodium alginateLife sciencePressurized gas

Ceapro Inc Announces Publication of Positive Results for PGX-Processed Alginates Impregnated with CoQ10 in The Journal of Supercritical Fluids

Ceapro Inc Announces Publication of Positive Results for PGX-Processed Alginates Impregnated with CoQ10 in The Journal of Supercritical Fluids
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bernhard seifriedGilles gagnonPaul moquinJenene thomasZixiang liuRicardo coutoXpanded liquid technologyUniversity of albertaCorporate communications advisorDepartment of agriculturalEngineering researchCeapro incFeral temelli at university of albertaSupercritical fluidsFeral temelliSodium alginate

Ceapro Inc Present PGX Enabling Technology Case Study at the 13th International Symposium on

EDMONTON, Alberta, May 13, 2022 (GLOBE NEWSWIRE) Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active

Bernhard seifriedJenene thomasCorporate communications advisorResearch technologyDepartment of agriculturalCeapro incInternational symposium on supercritical fluidsSenior directorFrom conceptInternational symposiumSupercritical fluidsPressurized gasFeral temelliNutritional scienceCorporate communications

Ceapro Inc Present PGX Enabling Technology Case Study at

PGX Technology continues to demonstrate ability to generate novel bioactive delivery systems for nutraceuticals, drug delivery and wound healing.

Bernhard seifriedJenene thomasCorporate communications advisorResearch technologyDepartment of agriculturalCeapro incInternational symposium on supercritical fluidsSenior directorFrom conceptInternational symposiumSupercritical fluidsPressurized gasFeral temelliNutritional scienceCorporate communicationsTsx venture exchange czo